-John D Morrey Researcher Activity Profile

Research Author Detailed Information 

John D Morrey Publication Rate By Year

John D Morrey has published 4 paper(s) in 2006, 8 paper(s) in 2007, 5 paper(s) in 2008, for a total of 17 research publications in total.

John D Jd Morrey Author Information

LAST NAME: morrey

FIRST NAME: John D

INITIALS: jd

AFFILIATION:

Papers

John D Morrey's Publication Record

1. Enhanced antiscrapie effect using combination drug treatment. Year Published: 2006
Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA. DKocisko@niaid.nih.gov
2. Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. Year Published: 2006
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322-4700, USA. jmorrey@cc.usu.edu
3. Inhibition of hepatitis C replicon RNA synthesis by beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine: a specific inhibitor of hepatitis C virus replication. Year Published: 2006
Pharmasset Inc, Princeton, NJ, USA.
4. Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model. Year Published: 2007
Institute for Antiviral Research, Utah State University, Logan, UT 84322-5600, United States. jgjulander@cc.usu.edu
5. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Year Published: 2007
Institute for Antiviral Research, Utah State University, 5600 Old Main Hill, Logan, UT 84322-5600, USA. Rsidwell@cc.usu.edu
6. Caspase 3-dependent cell death of neurons contributes to the pathogenesis of West Nile virus encephalitis. Year Published: 2007
Division of Infectious Diseases, Department of Medicine, Washington University School of Medicine, Campus Box 8051, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.
7. Effect of exogenous interferon and an interferon inducer on western equine encephalitis virus disease in a hamster model. Year Published: 2007
Institute for Antiviral Research, Utah State University, Logan, UT 84322-5600, USA. jgjulander@cc.usu.edu
8. Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model. Year Published: 2007
Institute for Antiviral Research, Animal, Dairy, and Veterinary Sciences Department, Utah State University, 4700 Old Main Hill, Logan, UT 84322-4700, USA. jmorrey@cc.usu.edu
9. Neutralizing viruses in suspensions by copper oxide-based filters. Year Published: 2007
Ruth Ben-Ari Institute of Clinical Immunology, Kaplan Medical Center, Rehovot 76100, Israel. gadi@cupron.com
10. Axonal transport mediates West Nile virus entry into the central nervous system and induces acute flaccid paralysis. Year Published: 2007
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
11. Increased blood brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. Year Published: 2008
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322-4700, USA.
12. Increased blood brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. Year Published: 2008
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322-4700, USA.
13. Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters. Year Published: 2006
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322-4700, USA. jmorrey@cc.usu.edu
14. Correlation between breakdown of the blood-brain barrier and disease outcome of viral encephalitis in mice. Year Published: 2007
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, 5600 Old Main Hill, Logan, UT 84322-5600, USA. alo@cc.usu.edu
15. Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. Year Published: 2008
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322-4700, USA. jmorrey@cc.usu.edu
16. C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Year Published: 2008
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, 5600 Old Main Hill, Logan, UT 84322-5600, United States.
17. Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents. Year Published: 2008
Institute for Antiviral Research, Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, UT 84322-4700, USA. jmorrey@cc.usu.edu